2/14/2008

Acambis PLC announced an anticipated deal to provide its ACAM2000 smallpox vaccine to the U.S. Defense Department, moving the company closer to securing a "warm-based" contract. An analyst said the annual revenue stream will help Acambis fund its R&D.

Full Story:
CNNMoney

Related Summaries